The Egyptian American Enterprise Fund (EAEF) announced acquiring a 46.5% stake in Orchidia Pharmaceutical Industries, the company announced a week earlier. Lorax Capital Partners (LCP), EAEF’s investment manager will organize fund transactions of staked owned by SPE Capital (formerly Swicorp Private Equity) and other minority shareholders. EAEF purchased 38% from SPE and 3% from the …